In this issue:
High risk of VTE in men with prostate cancer
Rilzabrutinib rapidly and durably increases platelet counts in ITP
Superior haemostasis-sparing anticoagulation with asundexian vs apixaban in AF
Increased risk of thromboembolic events in patient with nephrotic syndrome
No acute benefit to antiplatelet therapy for critical COVID
Predictors of bleeding in patients receiving DOACs
Combining aspirin with anticoagulants increases bleeding risk in PV
HU and IFN- α both effective for high-risk PV and ET
LA stability not prognostic for future thrombotic risk or mortality
Inhibition of APC anticoagulant activity may prevent joint damage in haemophilia
Please login below to download this issue (PDF)